Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline
about
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.The role of telavancin in hospital-acquired pneumonia and ventilator-associated pneumonia.Frequentist and Bayesian pharmacometric-based approaches to facilitate critically needed new antibiotic development: overcoming lies, damn lies, and statistics.Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary DiseaseTigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on.The challenge of antimicrobial resistance: new regulatory tools to support product development.Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia.Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A Review.Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections.A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center.Mutant prevention concentration of tigecycline for clinical isolates of Streptococcus pneumoniae and Staphylococcus aureus.Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group.Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed.Busting the Myth of "Static vs. Cidal": A Systemic Literature Review.Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
P2860
Q34274190-80E77C98-C1C6-4C99-97C8-0BDF2206A4DAQ34672655-D421D4F4-87CB-4575-8FB6-6A68EA5F839EQ35806456-2B4836D8-33AF-445C-8FD1-154403C6C90EQ36078359-27A0308F-AE55-4057-BCFF-AE96227DC594Q36757628-0E201928-0E9D-4450-8AB8-79E935F263ACQ36887811-D2183512-55F6-4D95-AC73-88DBE8BD476EQ37511815-A7A21E39-A205-4DA6-BD66-B80D40112297Q38115356-E71A2374-1A8A-4613-B682-9F9F12F01151Q38211473-382DB551-685E-4797-9C74-F9060F2F395DQ38216016-A490E0A6-683D-4E49-8A3D-CE477678877DQ38867747-0478284B-C7C5-41EC-B016-8341D41BE0CBQ38944862-ACED6AAC-D9F7-4E3F-ADB2-5ED3E619386AQ39167693-B19C7FF2-988A-43AA-9E07-3E330415ACBBQ40175198-22A08186-4BDB-451A-8C0F-5FBDE41E369FQ41111507-9F861887-CBBB-4371-A195-9D998A859CBBQ41676553-809E5514-617C-4055-A764-8381D0BF9DEDQ41697443-02993474-D5FD-42F5-BDE9-88AC94F5C4FBQ42258248-9392FA35-7BF8-44DE-BF0E-4168E8694A67Q43226964-B1B40C8C-77E7-4AA7-BCA9-BC91B71467A4Q47223062-C7424674-8D95-41F9-ACE8-60C61D33EAF4Q47662018-8E6E782F-D434-485E-8127-5FFF66FC4A0B
P2860
Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pharmacological and patient-sp ...... monia treated with tigecycline
@ast
Pharmacological and patient-sp ...... monia treated with tigecycline
@en
type
label
Pharmacological and patient-sp ...... monia treated with tigecycline
@ast
Pharmacological and patient-sp ...... monia treated with tigecycline
@en
prefLabel
Pharmacological and patient-sp ...... monia treated with tigecycline
@ast
Pharmacological and patient-sp ...... monia treated with tigecycline
@en
P2093
P2860
P356
P1476
Pharmacological and patient-sp ...... monia treated with tigecycline
@en
P2093
Alan Forrest
C Angel Cooper
Christopher M Rubino
Jeffrey P Hammel
Joan Korth-Bradley
Nathalie Dartois
Paul G Ambrose
Sujata M Bhavnani
P2860
P304
P356
10.1128/AAC.01615-10
P407
P577
2011-12-05T00:00:00Z